Steroid Dosing in HSP Vasculitis After Pulse Methylprednisolone

Initial Oral Steroid Regimen

The American College of Rheumatology recommends that after pulse methylprednisolone therapy for Henoch-Schönlein Purpura (HSP) vasculitis, oral prednisone should be started at 1 mg/kg/day (maximum 60 mg/day) for one month, followed by a gradual taper over 3-6 months depending on clinical response 1
Following methylprednisolone pulse therapy, transition to oral prednisone at 1 mg/kg/day (maximum 60 mg/day) 2, 1
Maintain this initial high dose for 1 month to ensure adequate disease control 3, 1
The oral dose should not be reduced to less than 15 mg/day during the first 3 months of treatment 3

After the first month of high-dose therapy, begin tapering the prednisone dose gradually 3, 1
Aim for a maintenance dose of 10 mg/day or less during remission 3
Complete tapering over 3-6 months depending on clinical response and disease severity 1

Regularly assess for signs of disease recurrence during the tapering process 1
Monitor for common steroid-related adverse effects including mood changes, weight gain, hypertension, hyperglycemia, and bone density loss 2
Consider prophylaxis against Pneumocystis jiroveci in patients receiving prolonged high-dose steroids 3

Dexamethasone pulse therapy (40 mg/day for 4 days) can be considered as an alternative to daily prednisone in some cases, with potentially fewer long-term side effects 2, 4
Multiple cycles of dexamethasone (40 mg/day for 4 days given every 14 days) have shown high response rates in other vasculitic conditions 2
Oral dexamethasone can be used instead of intravenous administration while maintaining the same pulsed dosing schedule 4

In cases with persistent disease activity despite standard therapy, consider additional immunomodulatory treatments 1